Literature DB >> 25317743

Ebola virus disease in the Democratic Republic of Congo.

Gaël D Maganga1, Jimmy Kapetshi, Nicolas Berthet, Benoît Kebela Ilunga, Felix Kabange, Placide Mbala Kingebeni, Vital Mondonge, Jean-Jacques T Muyembe, Eric Bertherat, Sylvie Briand, Joseph Cabore, Alain Epelboin, Pierre Formenty, Gary Kobinger, Licé González-Angulo, Ingrid Labouba, Jean-Claude Manuguerra, Jean-Marie Okwo-Bele, Christopher Dye, Eric M Leroy.   

Abstract

BACKGROUND: The seventh reported outbreak of Ebola virus disease (EVD) in the equatorial African country of the Democratic Republic of Congo (DRC) began on July 26, 2014, as another large EVD epidemic continued to spread in West Africa. Simultaneous reports of EVD in equatorial and West Africa raised the question of whether the two outbreaks were linked.
METHODS: We obtained data from patients in the DRC, using the standard World Health Organization clinical-investigation form for viral hemorrhagic fevers. Patients were classified as having suspected, probable, or confirmed EVD or a non-EVD illness. Blood samples were obtained for polymerase-chain-reaction-based diagnosis, viral isolation, sequencing, and phylogenetic analysis.
RESULTS: The outbreak began in Inkanamongo village in the vicinity of Boende town in Équateur province and has been confined to that province. A total of 69 suspected, probable, or confirmed cases were reported between July 26 and October 7, 2014, including 8 cases among health care workers, with 49 deaths. As of October 7, there have been approximately six generations of cases of EVD since the outbreak began. The reported weekly case incidence peaked in the weeks of August 17 and 24 and has since fallen sharply. Genome sequencing revealed Ebola virus (EBOV, Zaire species) as the cause of this outbreak. A coding-complete genome sequence of EBOV that was isolated during this outbreak showed 99.2% identity with the most closely related variant from the 1995 outbreak in Kikwit in the DRC and 96.8% identity to EBOV variants that are currently circulating in West Africa.
CONCLUSIONS: The current EVD outbreak in the DRC has clinical and epidemiologic characteristics that are similar to those of previous EVD outbreaks in equatorial Africa. The causal agent is a local EBOV variant, and this outbreak has a zoonotic origin different from that in the 2014 epidemic in West Africa. (Funded by the Centre International de Recherches Médicales de Franceville and others.).

Entities:  

Mesh:

Year:  2014        PMID: 25317743     DOI: 10.1056/NEJMoa1411099

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  94 in total

Review 1.  A tug-of-war between the host and the pathogen generates strategic hotspots for the development of novel therapeutic interventions against infectious diseases.

Authors:  Aarti Rana; Mushtaq Ahmed; Abdur Rub; Yusuf Akhter
Journal:  Virulence       Date:  2015-06-24       Impact factor: 5.882

2.  Puzzling Origins of the Ebola Outbreak in the Democratic Republic of the Congo, 2014.

Authors:  Tommy Tsan-Yuk Lam; Huachen Zhu; Yee Ling Chong; Edward C Holmes; Yi Guan
Journal:  J Virol       Date:  2015-07-22       Impact factor: 5.103

3.  Ebola vaccination in the Democratic Republic of the Congo.

Authors:  Chad R Wells; Abhishek Pandey; Alyssa S Parpia; Meagan C Fitzpatrick; Lauren A Meyers; Burton H Singer; Alison P Galvani
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-29       Impact factor: 11.205

4.  Characterizing the reproduction number of epidemics with early subexponential growth dynamics.

Authors:  Gerardo Chowell; Cécile Viboud; Lone Simonsen; Seyed M Moghadas
Journal:  J R Soc Interface       Date:  2016-10       Impact factor: 4.118

Review 5.  The evolution of Ebola virus: Insights from the 2013-2016 epidemic.

Authors:  Edward C Holmes; Gytis Dudas; Andrew Rambaut; Kristian G Andersen
Journal:  Nature       Date:  2016-10-13       Impact factor: 49.962

6.  Development of a Prediction Model for Ebola Virus Disease: A Retrospective Study in Nzérékoré Ebola Treatment Center, Guinea.

Authors:  Paul Loubet; Romain Palich; Richard Kojan; Olivier Peyrouset; Christine Danel; Sarala Nicholas; Mamoudou Conde; Klaudia Porten; Augustin Augier; Yazdan Yazdanpanah
Journal:  Am J Trop Med Hyg       Date:  2016-10-10       Impact factor: 2.345

7.  Transmission dynamics of Ebola virus disease and intervention effectiveness in Sierra Leone.

Authors:  Li-Qun Fang; Yang Yang; Jia-Fu Jiang; Hong-Wu Yao; David Kargbo; Xin-Lou Li; Bao-Gui Jiang; Brima Kargbo; Yi-Gang Tong; Ya-Wei Wang; Kun Liu; Abdul Kamara; Foday Dafae; Alex Kanu; Rui-Ruo Jiang; Ye Sun; Ruo-Xi Sun; Wan-Jun Chen; Mai-Juan Ma; Natalie E Dean; Harold Thomas; Ira M Longini; M Elizabeth Halloran; Wu-Chun Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-28       Impact factor: 11.205

8.  Sparks creating light? Strengthening peripheral disease surveillance in the Democratic Republic of Congo.

Authors:  G Benedetti; M Mossoko; J P Nyakio Kakusu; J Nyembo; J P Mangion; D Van Laeken; R Van den Bergh; W Van den Boogaard; M Manzi; W K Kibango; V Hermans; J Beijnsberger; V Lambert; E Kitenge
Journal:  Public Health Action       Date:  2016-06-21

9.  The Western Africa ebola virus disease epidemic exhibits both global exponential and local polynomial growth rates.

Authors:  Gerardo Chowell; Cécile Viboud; James M Hyman; Lone Simonsen
Journal:  PLoS Curr       Date:  2015-01-21

10.  Thermostable Ebola virus vaccine formulations lyophilized in the presence of aluminum hydroxide.

Authors:  Carly Fleagle Chisholm; Taek Jin Kang; Miao Dong; Kasey Lewis; Madhuri Namekar; Axel T Lehrer; Theodore W Randolph
Journal:  Eur J Pharm Biopharm       Date:  2019-01-28       Impact factor: 5.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.